Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitis.

Abstract:

BACKGROUND & AIMS

Severe alcohol-related hepatitis (AH) and acute variceal bleeding (AVB) may occur simultaneously. The impact of a pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) in high-risk patients (patients with Child-Pugh (CP) B and active bleeding or CP C10-13 cirrhosis) with AVB and concomitant severe AH is unknown. The objective of the study was to compare the outcomes of severe AH in patients with high-risk AVB treated with pTIPS or endoscopic and drug treatment (Endo+drugs).

METHODS

Patients were screened in four existing cohorts of patients with cirrhosis and AVB treated either with pTIPS or Endo+drugs. The inclusion criteria were AVB, high-risk patients, suspected severe AH (recent onset of jaundice, alcohol-related liver disease, absence of abstinence, model for end-stage liver disease score >20 and aspartate aminotransferase <500 UI/L). The primary endpoint was 42-day mortality, considering liver transplantation as a competing event. Secondary endpoints were rebleeding and further development of ascites or hepatic encephalopathy at 6 months.

RESULTS

A total of 142 patients with AVB were included (pTIPS: n = 47, Endo+drugs: n = 95). Baseline characteristics (age 53, male sex 84%, model for end-stage liver disease score 23.4) were similar between the two groups. Overall, 56% had histologically proven AH. The 42-day mortality was 16% in the pTIPS group 30% in the Endo+drugs group ( = 0.2). The cumulative incidence of rebleeding and ascites was significantly lower in the pTIPS group (2.8% 24%, = 0.026, and 6% 52%, <0.001, respectively), whereas hepatic encephalopathy occurrence was similar in the two groups ( = 0.2). Corticosteroid therapy was given in 55% and 46% of patients in the pTIPS and Endo+drugs groups, respectively ( = 0.3).

CONCLUSIONS

In severe AH, pTIPS is associated with better outcomes than Endo+drugs, and should not be contraindicated.

IMPACT AND IMPLICATIONS

Severe alcohol-related hepatitis and acute variceal bleeding may occur concomitantly, yet the role of pre-emptive transjugular intrahepatic portosystemic shunt (pTIPS) placement in this setting remains unclear. In this study, compared to standard of care, pTIPS treatment was associated with lower mortality, although this difference did not reach statistical significance, as well as a significantly reduced risk of rebleeding and recurrent ascites. These findings suggest that severe alcohol-related hepatitis should not be viewed as a contraindication to pTIPS placement when otherwise indicated, such as in patients with Child-Pugh B cirrhosis with a score greater than 7 and active bleeding, or Child-Pugh C10-13 disease.

Keywords: Acute variceal bleeding, Cirrhosis, Portal hypertension, Severe alcohol-related hepatitis, TIPS

References: García-Pagán J.C., Caca K., Bureau C., et al. Early TIPS (Transjugular intrahepatic portosystemic shunt) cooperative study group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362:2370–2379.
Garcia-Pagán J.C., Di Pascoli M., Caca K., et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol. 2013;58:45–50.
Nicoară-Farcău O., Han G., Rudler M., et al. Preemptive TIPS Individual Data Metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups. Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data. Gastroenterology. 2021;160:193–205.e10.
Nicoară-Farcău O., Han G., Rudler M., et al. Pre-emptive TIPS Individual Data Metanalysis, International Variceal Bleeding Study and Baveno Cooperation Study groups. Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis. Hepatology. 2024;79:624–635.
Trebicka J., Gu W., Ibáñez-Samaniego L., et al. International variceal bleeding observational study group and Baveno cooperation. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS. J Hepatol. 2020;73:1082–1091.
Hernández-Gea V., Procopet B., Giráldez Á., et al. International variceal bleeding observational study group and Baveno cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study. Hepatology. 2019;69:282–293.
Rudler M., Cluzel P., Corvec T.L., et al. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther. 2014;40:1074–1080.
Louvet A., Labreuche J., Artru F., et al. Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis. Gastroenterology. 2015;149:398–406. e8.quiz e16-7.116.
Louvet A., Naveau S., Abdelnour M., et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–1354.
Rudler M., Mouri S., Charlotte F., et al. Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding. J Hepatol. 2015;62:816–821.
Louvet A., Labreuche J., Dao T., et al. Effect of prophylactic antibiotics on mortality in severe alcohol-related hepatitis: a randomized clinical trial. JAMA. 2023;329:1558–1566.
Mathurin P., Louvet A., Duhamel A., et al. Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial. JAMA. 2013;310:1033–1041.
Thursz M.R., Richardson P., Allison M., et al. STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–1628.
Bouzbib A., Hernández-Gea V., Bataller R., et al. International Variceal Bleeding Observational Study Group; Baveno Cooperation. Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode. Liver Int. 2023;43:1548–1557.
Crabb D.W., Bataller R., Chalasani N.P., et al. NIAAA Alcoholic Hepatitis Consortia. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150:785–790.
de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–176.
de Franchis R., Baveno V. Faculty. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–768.
de Franchis R., VI Faculty Baveno. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743–752.
de Franchis R., Bosch J., Garcia-Tsao G., et al. Baveno VII faculty. Baveno VII - renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974.
Louvet A., Labreuche J., Moreno C., et al. QuickTrans trial study group. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study. Lancet Gastroenterol Hepatol. 2022;7:416–425.
Altamirano J., López-Pelayo H., Michelena J., et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology. 2017;66:1842–1853.
Rudler M., Hernández-Gea V., Procopet B.D., et al. For International Variceal Bleeding Observational Study Group: a Baveno Cooperation. Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. Gut. 2023;72:749–758.

Authors

Elsevier Science
Full Text Sources - free resource

Journal Title: JHEP reports : innovation in hepatology

Journal ISSN: 2589-5559

Journal ISO Abbreviation: JHEP Rep

Publication Date: 2025-12-01

DOI: 10.1016/j.jhepr.2025.101611

Volume: 7

Issue: 12

Start Page: 101611